State Street Corp Akebia Therapeutics, Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,747,240 shares of AKBA stock, worth $3.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,747,240
Previous 650,350
322.42%
Holding current value
$3.65 Million
Previous $1.19 Million
135.46%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AKBA
# of Institutions
110Shares Held
55.3MCall Options Held
554KPut Options Held
246K-
Black Rock Inc. New York, NY11.6MShares$15.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.28MShares$12.3 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$7.64 Million11.5% of portfolio
-
Geode Capital Management, LLC Boston, MA4.54MShares$6.03 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA4.06MShares$5.4 Million0.01% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $245M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...